Validation of PIVKA-II as a useful marker for detecting and monitoring hepatocellular carcinoma

被引：0
|
作者：
Lee, Sung W. [1 ]
Han, Sang Y. [1 ]
Choi, Jong C. [1 ]
机构：
[1] Dong A Univ Coll Med, Pusan, South Korea
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
868
引用
收藏
页码：511A / 511A
页数：1
相关论文
共 50 条
  • [31] Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin
    Qian, Xiang-Jun
    Wen, Zhu-Mei
    Huang, Xiao-Ming
    Feng, Hui-Juan
    Lin, Shan-Shan
    Liu, Yan-Na
    Li, Sheng-Cong
    Zhang, Yu
    Peng, Wen-Guang
    Yang, Jia-Rui
    Zheng, Zhe-Yu
    Zhang, Lei
    Zhang, Da-Wei
    Lu, Feng-Min
    Liu, Li-Juan
    Pan, Wei-Dong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (08) : 1359 - 1373
  • [32] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
    Honglei Feng
    Bole Li
    Ze Li
    Qian Wei
    Li Ren
    BMC Cancer, 21
  • [33] Usefulness of DCP assay method (PIVKA-II IRMA "Daiichi") for hepatocellular carcinoma
    Takahashi, Y
    Shinbata, H
    Yagi, S
    Narimatsu, T
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1204 - 1204
  • [34] Clinical significance of PIVKA-II levels after liver transplantation for hepatocellular carcinoma
    Villalba, F.
    Alconchel, F.
    Saenz, L.
    Sanchez, M. I.
    Ferreras, D.
    Cascales, P.
    Robles, R.
    Sanchez-Bueno, F.
    Ramirez, P.
    TRANSPLANTATION, 2022, 106 (8S) : 168 - 168
  • [35] Usefulness of PIVKA-II after Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Park, Min-Su
    Lee, Kwang-Woong
    Choi, YoungRok
    Suh, Suk-Won
    Lee, Jeong-Moo
    Yi, Nam-Joon
    Suh, Kyung-Suk
    LIVER TRANSPLANTATION, 2014, 20 : S184 - S184
  • [36] Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
    An, Shu
    Zhan, Xiaoxia
    Liu, Min
    Li, Laisheng
    Wu, Jian
    DIAGNOSTICS, 2023, 13 (08)
  • [37] The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
    Basile, U.
    Miele, L.
    Napodano, C.
    Ciasca, G.
    Gulli, F.
    Pocino, K.
    De Matthaeis, N.
    Liguori, A.
    De Magistris, A.
    Marrone, G.
    Biolato, M.
    Marino, M.
    Di Giacinto, F.
    Gasbarrini, A.
    Grieco, A.
    Rapaccini, G. L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (24) : 12675 - 12685
  • [38] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
    Feng, Honglei
    Li, Bole
    Li, Ze
    Wei, Qian
    Ren, Li
    BMC CANCER, 2021, 21 (01)
  • [39] ACARBOXY PROTHROMBIN (PIVKA-II) AS A MARKER OF HEPATOBLASTOMA IN INFANTS
    MOTOHARA, K
    ENDO, F
    MATSUDA, I
    IWAMASA, T
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1987, 6 (01): : 42 - 45
  • [40] Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
    Pote, Nicolas
    Cauchy, Franois
    Albuquerque, Miguel
    Voitot, Helene
    Belghiti, Jacques
    Castera, Laurent
    Puy, Herve
    Bedossa, Pierre
    Paradis, Valerie
    JOURNAL OF HEPATOLOGY, 2015, 62 (04) : 848 - 854
12345